Business

Global Antisense & RNAi Therapeutics Market 2019| Latest Growth, Key Trends, Challenges and Opportunities 2025

Researchmoz added Most up-to-date research on "Global Antisense & RNAi Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”.
North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2057188

In 2018, the global Antisense & RNAi Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antisense & RNAi Therapeutics development in United States, Europe and China.

The key players covered in this study
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.

Market segment by Type, the product can be split into
RNA interference
SiRNA
MiRNA
Antisense RNA

Market segment by Application, split into
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases

View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-antisense-and-rnai-therapeutics-market-size-status-and-forecast-2019-2025-report.html/toc

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Antisense & RNAi Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: [email protected] ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at:https://marketreserch1.blogspot.com

Tags

Related Articles

Close